Article
Berberine Impairs the Survival of Triple Negative Breast Cancer Cells: Cellular and Molecular Analyses
24 Jan 2020
Abstract excerpt
Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype. Non-available targeted therapy for TNBC represents its biggest treatment challenge. Thus, finding new promising effective drugs is urgently needed. In the present study, we investigated how berberine, a natural isoquinoline, impairs the survival of TNBC cells in both cellular and molecular levels. Our experimental model was based on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
